Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Status:
Completed
Trial end date:
2012-09-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and effectiveness of
DS-5565 compared to placebo (inactive substance) and pregabalin in diabetic subjects with
DPN.